VF
TSBX

Virtu Financial’s Turnstone Biologics TSBX Stock Holding History

Virtu Financial’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,810
Closed -$7K – 2045
2024
Q4 		$7K Buy
+14,810
New +$7.32K ﹤0.01% 1417
2024
Q3 		– Sell
-13,954
Closed -$37K – 1895
2024
Q2 		$37K Buy
+13,954
New +$39.9K ﹤0.01% 948

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's TSBX Position: Q1 2025 in Review

Virtu Financial sold out of Turnstone Biologics (TSBX) in Q1 2025, closing a stake of 14,810 shares — an estimated $7K sold.

Virtu Financial first reported a position in TSBX in Q2 2024 and held it in 2 quarters. The position peaked at $37K in Q2 2024. 23 funds tracked by Wall St. Rank hold TSBX as of Q1 2025.

  • Virtu Financial reported no remaining Turnstone Biologics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 14,810 Turnstone Biologics shares in Q1 2025, an estimated $7K.
  • Virtu Financial first reported a position in Turnstone Biologics in Q2 2024 and held it in 2 quarters.
  • Virtu Financial's Turnstone Biologics position peaked at $37K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Turnstone Biologics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.